Continued Peer Reviewer Representation Consultant Speaker s Bureau Ownership/ Partnership/ Principal Personal Research Institutional, Organizational, or Other Financial Benefit Expert Witness Frederick A. Masoudi Content Reviewer ACC NCDR Science and Quality Oversight Committee Content Reviewer AHA None None None None None None Laura Mauri Official Reviewer AHA Abbott Cordis Johnson & Johnson Medtronic None None Abbott Abiomed Boston Scientific Bristol-Myers Squibb Cordis Daiichi Sankyo Eli Lilly Johnson & Johnson Medtronic Sanofi-Aventis Harvard Clinical Research Institute None None James K. Min Content Reviewer ACC Appropriate Use Criteria Task Force None GE Healthcare TC3* Phillips Healthcare* Arineta* None None Manesh R. Patel Content Reviewer ACC Appropriate Use Criteria Task Force None None None None None None Eric D. Peterson Official Reviewer ACC/AHA Task Force on Performance Measures Boehringer Ingelheim Genentech Janssen Pharmaceuticals Johnson & Johnson Merck None None Eli Lilly Johnson & Johnson Janssen Pharmaceuticals DCRI None Sunil V. Rao Official Reviewer SCAI AstraZeneca Bristol-Myers Squibb Cordis Daiichi Sankyo Terumo Medical The Medicines Company None None Sanofi-Aventis Abbott Vascular* None None Matthew T. Roe Content Reviewer ACC NCDR Science and Quality Oversight Committee KAI Pharmaceuticals Daiichi Sankyo GlaxoSmithKline Janssen Pharmaceuticals Eli Lilly Bristol-Myers Squibb Sanofi-Aventis None AstraZeneca Bristol-Myers Squibb Eli Lilly Merck Roche Pharmaceuticals Sanofi-Aventis AstraZeneca* AstraZeneca lectures performed within DCRI None Frank Rybicki Content Reviewer ACC/AHA/ACR/AMA- PCPI/NCQA Cardiac Imaging Writing Committee None None None Bracco Diagnostics Toshiba Medical Systems None None Leslee Shaw Content Reviewer ACC Appropriate Use Criteria Task Force None None None Bracco Diagnostics None None Marc Shelton Content Reviewer ACC Board of Governors None None None None None None John Spertus Content Reviewer ACC Appropriate Use Criteria Coronary Revascularization Genentech United Healthcare Scientific Advisory Board Amgen None None Eli Lilly CV Outcomes* None (Continued) Nallamothu et al ACC/AHA/SCAI/AMA-PCPI/NCQA 2013 PCI Performance Measure 947 Appendix B. Continued Peer Reviewer Representation Consultant Speaker s Bureau Ownership/ Partnership/ Principal Personal Research Institutional, Organizational, or Other Financial Benefit Expert Witness Raymond F. Stainback Content Reviewer ACC Appropriate Use Criteria Task Force None None None None None None Eric Stecker Content Reviewer ACC Clinical Quality Committee None None None Biotronik Medtronic Boston Scientific None None James E. Tcheng Content Reviewer ACC/AHA Task Force on Data Standards None None None Philips Medical Systems None None Randal J. Thomas Organizational Reviewer AACVPR None None None None None None Thomas T. Tsai Content Reviewer ACC NCDR Science and Quality Oversight Committee None None None None None None Thad Waites Official Reviewer ACC Board of Trustees None None None None None None Tracy Y. Wang Content Reviewer ACC/AHA Task Force on Data Standards AstraZeneca Medco Health Solutions None None Bristol-Myers Squibb Canyon Pharmaceuticals Daiichi Sankyo Eli Lilly Heartscape Merck Sanofi-Aventis The Medicines Company Gilead None None Michael J. Wolk Content Reviewer ACC Appropriate Use Criteria Task Force None None None None None None This table represents the relationships of reviewers with industry and other entities that were disclosed at the time of peer review and determined to be relevant. 